Regulation of proteasome activity in activated human platelets

Cell Calcium. 2011 Apr;49(4):226-32. doi: 10.1016/j.ceca.2011.02.005. Epub 2011 Mar 8.

Abstract

Ubiquitin-proteasome system has emerged a central player in regulation of diverse cellular processes. However, relevance of proteasome activity in platelets, which are terminally differentiated enucleate cells, is not clear. In this report we show that activation of platelets with physiological agonists was associated with 7-10 -fold rise in proteasomal activity. Elevation of cytosolic calcium with A23187 or thapsigargin resulted in significant increase in enzymatic activity, while treatment with intracellular calcium chelator or inhibitor of inositol trisphosphate receptor attenuated proteasomal enzymes in collagen-stimulated platelets. Specific inhibitors of protein kinase C as well as calpain, too, downregulated proteasome function. To conclude, proteasomal enzymatic activity in platelets is regulated by cytosolic calcium through Ca(2+)-dependent downstream effectors like calpain and protein kinase C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / enzymology*
  • Calcimycin / pharmacology
  • Calcium / metabolism
  • Calpain / antagonists & inhibitors
  • Calpain / metabolism
  • Chelating Agents / pharmacology
  • Down-Regulation
  • Humans
  • Inositol 1,4,5-Trisphosphate Receptors / antagonists & inhibitors
  • Inositol 1,4,5-Trisphosphate Receptors / metabolism
  • Proteasome Endopeptidase Complex / chemistry
  • Proteasome Endopeptidase Complex / metabolism*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Thapsigargin / pharmacology

Substances

  • Chelating Agents
  • Inositol 1,4,5-Trisphosphate Receptors
  • Calcimycin
  • Thapsigargin
  • Protein Kinase C
  • Calpain
  • Proteasome Endopeptidase Complex
  • Calcium